Association of Left Atrial Size With Stroke or Systemic Embolism in Patients With Atrial Fibrillation Having Undergone Bioprosthetic Valve Replacement From the BPV-AF Registry

Background: The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the utility of LAVI for predicting thromboembolism in patients with both bioprosthetic valve replacement and AF remains unclear.Methods and Results:...

Full description

Saved in:
Bibliographic Details
Published in:Circulation Reports Vol. 5; no. 5; pp. 210 - 216
Main Authors: Tanaka, Hidekazu, Takegami, Misa, Miyake, Makoto, Amano, Masashi, Kitai, Takeshi, Fujita, Tomoyuki, Koyama, Tadaaki, Ando, Kenji, Komiya, Tatsuhiko, Izumo, Masaki, Kawai, Hiroya, Eishi, Kiyoyuki, Yoshida, Kiyoshi, Kimura, Takeshi, Nawada, Ryuzo, Sakamoto, Tomohiro, Shibata, Yoshisato, Fukui, Toshihiro, Minatoya, Kenji, Tsujita, Kenichi, Sakata, Yasushi, Kimura, Tetsuya, Nishimura, Kunihiro, Furukawa, Yutaka, Izumi, Chisato, for the BPV-AF Registry Group
Format: Journal Article
Language:English
Published: Japan The Japanese Circulation Society 10-05-2023
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background: The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the utility of LAVI for predicting thromboembolism in patients with both bioprosthetic valve replacement and AF remains unclear.Methods and Results: Of 894 patients from a previous multicenter prospective observational registry (BPV-AF Registry), 533 whose LAVI data had been obtained by transthoracic echocardiography were included in this subanalysis. Patients were divided into tertiles (T1–T3) according to LAVI as follows: T1 (n=177), LAVI=21.5–55.3 mL/m2; T2 (n=178), LAVI=55.6–82.1 mL/m2; T3 (n=178), LAVI=82.5–408.0 mL/m2. The primary outcome was defined as either stroke or systemic embolism for a mean (±SD) follow-up period of 15.3±4.2 months. Kaplan-Meier curves indicated that the primary outcome tended to occur more frequently in the group with the larger LAVI (log-rank P=0.098). Comparison of T1 with T2 plus T3 using Kaplan-Meier curves indicated that patients in T1 experienced significantly fewer primary outcomes (log-rank P=0.028). Furthermore, univariate Cox proportional hazard regression showed that 1.3- and 3.3-fold more primary outcomes occurred in T2 and T3, respectively, than in T1.Conclusions: Larger LAVI was associated with stroke or systemic embolism in patients who had undergone bioprosthetic valve replacement and with a definitive diagnosis of AF.
AbstractList The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the utility of LAVI for predicting thromboembolism in patients with both bioprosthetic valve replacement and AF remains unclear. Of 894 patients from a previous multicenter prospective observational registry (BPV-AF Registry), 533 whose LAVI data had been obtained by transthoracic echocardiography were included in this subanalysis. Patients were divided into tertiles (T1-T3) according to LAVI as follows: T1 (n=177), LAVI=21.5-55.3 mL/m ; T2 (n=178), LAVI=55.6-82.1 mL/m ; T3 (n=178), LAVI=82.5-408.0 mL/m . The primary outcome was defined as either stroke or systemic embolism for a mean (±SD) follow-up period of 15.3±4.2 months. Kaplan-Meier curves indicated that the primary outcome tended to occur more frequently in the group with the larger LAVI (log-rank P=0.098). Comparison of T1 with T2 plus T3 using Kaplan-Meier curves indicated that patients in T1 experienced significantly fewer primary outcomes (log-rank P=0.028). Furthermore, univariate Cox proportional hazard regression showed that 1.3- and 3.3-fold more primary outcomes occurred in T2 and T3, respectively, than in T1. Larger LAVI was associated with stroke or systemic embolism in patients who had undergone bioprosthetic valve replacement and with a definitive diagnosis of AF.
Background: The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the utility of LAVI for predicting thromboembolism in patients with both bioprosthetic valve replacement and AF remains unclear.Methods and Results: Of 894 patients from a previous multicenter prospective observational registry (BPV-AF Registry), 533 whose LAVI data had been obtained by transthoracic echocardiography were included in this subanalysis. Patients were divided into tertiles (T1–T3) according to LAVI as follows: T1 (n=177), LAVI=21.5–55.3 mL/m2; T2 (n=178), LAVI=55.6–82.1 mL/m2; T3 (n=178), LAVI=82.5–408.0 mL/m2. The primary outcome was defined as either stroke or systemic embolism for a mean (±SD) follow-up period of 15.3±4.2 months. Kaplan-Meier curves indicated that the primary outcome tended to occur more frequently in the group with the larger LAVI (log-rank P=0.098). Comparison of T1 with T2 plus T3 using Kaplan-Meier curves indicated that patients in T1 experienced significantly fewer primary outcomes (log-rank P=0.028). Furthermore, univariate Cox proportional hazard regression showed that 1.3- and 3.3-fold more primary outcomes occurred in T2 and T3, respectively, than in T1.Conclusions: Larger LAVI was associated with stroke or systemic embolism in patients who had undergone bioprosthetic valve replacement and with a definitive diagnosis of AF.
Background: The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the utility of LAVI for predicting thromboembolism in patients with both bioprosthetic valve replacement and AF remains unclear. Methods and Results: Of 894 patients from a previous multicenter prospective observational registry (BPV-AF Registry), 533 whose LAVI data had been obtained by transthoracic echocardiography were included in this subanalysis. Patients were divided into tertiles (T1-T3) according to LAVI as follows: T1 (n=177), LAVI=21.5-55.3 mL/m2; T2 (n=178), LAVI=55.6-82.1 mL/m2; T3 (n=178), LAVI=82.5-408.0 mL/m2. The primary outcome was defined as either stroke or systemic embolism for a mean (±SD) follow-up period of 15.3±4.2 months. Kaplan-Meier curves indicated that the primary outcome tended to occur more frequently in the group with the larger LAVI (log-rank P=0.098). Comparison of T1 with T2 plus T3 using Kaplan-Meier curves indicated that patients in T1 experienced significantly fewer primary outcomes (log-rank P=0.028). Furthermore, univariate Cox proportional hazard regression showed that 1.3- and 3.3-fold more primary outcomes occurred in T2 and T3, respectively, than in T1. Conclusions: Larger LAVI was associated with stroke or systemic embolism in patients who had undergone bioprosthetic valve replacement and with a definitive diagnosis of AF.Background: The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the utility of LAVI for predicting thromboembolism in patients with both bioprosthetic valve replacement and AF remains unclear. Methods and Results: Of 894 patients from a previous multicenter prospective observational registry (BPV-AF Registry), 533 whose LAVI data had been obtained by transthoracic echocardiography were included in this subanalysis. Patients were divided into tertiles (T1-T3) according to LAVI as follows: T1 (n=177), LAVI=21.5-55.3 mL/m2; T2 (n=178), LAVI=55.6-82.1 mL/m2; T3 (n=178), LAVI=82.5-408.0 mL/m2. The primary outcome was defined as either stroke or systemic embolism for a mean (±SD) follow-up period of 15.3±4.2 months. Kaplan-Meier curves indicated that the primary outcome tended to occur more frequently in the group with the larger LAVI (log-rank P=0.098). Comparison of T1 with T2 plus T3 using Kaplan-Meier curves indicated that patients in T1 experienced significantly fewer primary outcomes (log-rank P=0.028). Furthermore, univariate Cox proportional hazard regression showed that 1.3- and 3.3-fold more primary outcomes occurred in T2 and T3, respectively, than in T1. Conclusions: Larger LAVI was associated with stroke or systemic embolism in patients who had undergone bioprosthetic valve replacement and with a definitive diagnosis of AF.
Background: The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the utility of LAVI for predicting thromboembolism in patients with both bioprosthetic valve replacement and AF remains unclear. Methods and Results: Of 894 patients from a previous multicenter prospective observational registry (BPV-AF Registry), 533 whose LAVI data had been obtained by transthoracic echocardiography were included in this subanalysis. Patients were divided into tertiles (T1–T3) according to LAVI as follows: T1 (n=177), LAVI=21.5–55.3 mL/m 2 ; T2 (n=178), LAVI=55.6–82.1 mL/m 2 ; T3 (n=178), LAVI=82.5–408.0 mL/m 2 . The primary outcome was defined as either stroke or systemic embolism for a mean (±SD) follow-up period of 15.3±4.2 months. Kaplan-Meier curves indicated that the primary outcome tended to occur more frequently in the group with the larger LAVI (log-rank P=0.098). Comparison of T1 with T2 plus T3 using Kaplan-Meier curves indicated that patients in T1 experienced significantly fewer primary outcomes (log-rank P=0.028). Furthermore, univariate Cox proportional hazard regression showed that 1.3- and 3.3-fold more primary outcomes occurred in T2 and T3, respectively, than in T1. Conclusions: Larger LAVI was associated with stroke or systemic embolism in patients who had undergone bioprosthetic valve replacement and with a definitive diagnosis of AF.
ArticleNumber CR-23-0007
Author Nawada, Ryuzo
Izumi, Chisato
Miyake, Makoto
Sakamoto, Tomohiro
Tanaka, Hidekazu
Kimura, Tetsuya
Furukawa, Yutaka
Kitai, Takeshi
Izumo, Masaki
Fujita, Tomoyuki
Ando, Kenji
Sakata, Yasushi
Fukui, Toshihiro
for the BPV-AF Registry Group
Amano, Masashi
Eishi, Kiyoyuki
Tsujita, Kenichi
Nishimura, Kunihiro
Komiya, Tatsuhiko
Koyama, Tadaaki
Yoshida, Kiyoshi
Shibata, Yoshisato
Takegami, Misa
Kimura, Takeshi
Minatoya, Kenji
Kawai, Hiroya
Author_xml – sequence: 1
  fullname: Tanaka, Hidekazu
  organization: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine
– sequence: 2
  fullname: Takegami, Misa
  organization: Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center
– sequence: 3
  fullname: Miyake, Makoto
  organization: Department of Cardiology, Tenri Hospital
– sequence: 4
  fullname: Amano, Masashi
  organization: Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
– sequence: 5
  fullname: Kitai, Takeshi
  organization: Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
– sequence: 6
  fullname: Fujita, Tomoyuki
  organization: Cardiovascular Surgery Department, National Cerebral and Cardiovascular Center
– sequence: 7
  fullname: Koyama, Tadaaki
  organization: Department of Cardiovascular Surgery, Kobe City Medical Center General Hospital
– sequence: 8
  fullname: Ando, Kenji
  organization: Department of Cardiology, Kokura Memorial Hospital
– sequence: 9
  fullname: Komiya, Tatsuhiko
  organization: Department of Cardiovascular Surgery, Kurashiki Central Hospital
– sequence: 10
  fullname: Izumo, Masaki
  organization: Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine
– sequence: 11
  fullname: Kawai, Hiroya
  organization: Department of Cardiology, Hyogo Prefectural Harima-Himeji General Medical Center
– sequence: 12
  fullname: Eishi, Kiyoyuki
  organization: Department of Cardiovascular Surgery, Nagasaki University Hospital
– sequence: 13
  fullname: Yoshida, Kiyoshi
  organization: Department of Cardiology, The Sakakibara Heart Institute of Okayama
– sequence: 14
  fullname: Kimura, Takeshi
  organization: Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University
– sequence: 15
  fullname: Nawada, Ryuzo
  organization: Department of Cardiology, Shizuoka City Shizuoka Hospital
– sequence: 16
  fullname: Sakamoto, Tomohiro
  organization: Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center
– sequence: 17
  fullname: Shibata, Yoshisato
  organization: Department of Cardiology, Miyazaki Medical Association Hospital Cardiovascular Center
– sequence: 18
  fullname: Fukui, Toshihiro
  organization: Department of Cardiovascular Surgery, Graduate School of Medical Sciences, Kumamoto University
– sequence: 19
  fullname: Minatoya, Kenji
  organization: Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University
– sequence: 20
  fullname: Tsujita, Kenichi
  organization: Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University
– sequence: 21
  fullname: Sakata, Yasushi
  organization: Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine
– sequence: 22
  fullname: Kimura, Tetsuya
  organization: Primary Medical Science Department, Daiichi Sankyo Co., Ltd
– sequence: 23
  fullname: Nishimura, Kunihiro
  organization: Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center
– sequence: 24
  fullname: Furukawa, Yutaka
  organization: Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital
– sequence: 25
  fullname: Izumi, Chisato
  organization: Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
– sequence: 26
  fullname: for the BPV-AF Registry Group
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37180478$$D View this record in MEDLINE/PubMed
BookMark eNpVkd9u0zAUxiM0xMbYC3CBfMlNhv8lTq5QVy0MqRJTy8al5TonqUcSZ7ZbqbwUr4hHSjfsC1s63_c79vneJieDHSBJ3hN8SWjGPmnjtIPxcr5MKUsxxuJVckY54ykWJT55cT9NLrx_iApKOM8IfpOcMkEKzEVxlvyeeW-1UcHYAdkGLaAJaBacUR1amV-AfpiwQavg7E9A1qHV3gfojUbX_dp2xvfIDOg22mEIfhIf3JVZO9N1E_lG7czQoruhBtfGj6ArY0dnfdhAiLB71e0ALWHslIY-olDlbI9iFV3d3qezKtZa44Pbv0teN6rzcHE4z5O76vr7_CZdfPvydT5bpJozEdKy4FnTFARjQmsCPAcNmWhyqHPAuATO1kQrzLDgJaYFqZuSKJxhUVCdFzVl58nniTtu1z3UOr7JqU6OzvTK7aVVRv5fGcxGtnYnCSZ5XCISPh4Izj5uwQfZG68hTmQAu_UydmVFkYucRymdpDqOxDtojn0Ilk9py0Pacr6UlMmntKPpw8sXHi3_so2CahI8-KBaOAqUiyPv4MjM_u5n8rNgo5yEgf0Bb-nGRw
Cites_doi 10.7861/clinmedicine.10-2-168
10.1016/j.jacc.2005.08.077
10.1007/s11748-019-01068-9
10.5603/KP.2016.0172
10.1016/j.cjca.2017.12.008
10.1007/s12574-021-00561-6
10.1093/ehjci/jev014
10.4065/83.10.1107
10.1007/s10557-020-07038-1
10.1093/ejcts/ezac209
10.1161/01.CIR.98.10.946
10.1016/j.echo.2010.05.010
10.2147/CLEP.S47385
10.1007/s10554-021-02403-z
10.1016/S0002-9149(02)02864-3
10.1067/mhj.2003.91
10.1253/circj.CJ-21-0564
10.1016/j.cjca.2017.06.002
ContentType Journal Article
Copyright 2023, THE JAPANESE CIRCULATION SOCIETY
Copyright © 2023, THE JAPANESE CIRCULATION SOCIETY.
Copyright © 2023, THE JAPANESE CIRCULATION SOCIETY 2023 The Japanese Circulation Society 一般社団法人 日本循環器学会
Copyright_xml – notice: 2023, THE JAPANESE CIRCULATION SOCIETY
– notice: Copyright © 2023, THE JAPANESE CIRCULATION SOCIETY.
– notice: Copyright © 2023, THE JAPANESE CIRCULATION SOCIETY 2023 The Japanese Circulation Society 一般社団法人 日本循環器学会
CorporateAuthor BPV-AF Registry Group
for the BPV-AF Registry Group
CorporateAuthor_xml – name: BPV-AF Registry Group
– name: for the BPV-AF Registry Group
DBID NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1253/circrep.CR-23-0007
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList PubMed

MEDLINE - Academic

DeliveryMethod fulltext_linktorsrc
EISSN 2434-0790
EndPage 216
ExternalDocumentID 10_1253_circrep_CR_23_0007
37180478
article_circrep_5_5_5_CR_23_0007_article_char_en
Genre Journal Article
GroupedDBID 53G
ALMA_UNASSIGNED_HOLDINGS
JSF
JSH
M~E
OK1
RJT
RPM
RZJ
NPM
PGMZT
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c437t-9845ff810012d1e46ece57f6ed6e009e43b1ca0307490281df91a050782c68d23
IEDL.DBID RPM
ISSN 2434-0790
IngestDate Tue Sep 17 21:32:32 EDT 2024
Sat Oct 26 04:06:45 EDT 2024
Fri Aug 23 01:01:23 EDT 2024
Sat Nov 02 12:18:27 EDT 2024
Sun Jul 28 05:37:12 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 5
Keywords Bioprosthetic valve replacement
Thromboembolism
Left atrial volume index
Atrial fibrillation
Language English
License Copyright © 2023, THE JAPANESE CIRCULATION SOCIETY.
This article is licensed under a Creative Commons [Attribution-NonCommercial-NoDerivatives 4.0 International] license.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c437t-9845ff810012d1e46ece57f6ed6e009e43b1ca0307490281df91a050782c68d23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Hidekazu Tanaka, MD, PhD, FJCS
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166667/
PMID 37180478
PQID 2813886764
PQPubID 23479
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10166667
proquest_miscellaneous_2813886764
crossref_primary_10_1253_circrep_CR_23_0007
pubmed_primary_37180478
jstage_primary_article_circrep_5_5_5_CR_23_0007_article_char_en
PublicationCentury 2000
PublicationDate 2023-May-10
PublicationDateYYYYMMDD 2023-05-10
PublicationDate_xml – month: 05
  year: 2023
  text: 2023-May-10
  day: 10
PublicationDecade 2020
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Circulation Reports
PublicationTitleAlternate Circ Rep
PublicationYear 2023
Publisher The Japanese Circulation Society
Publisher_xml – name: The Japanese Circulation Society
References 17. Andrade JG, Macle L, Nattel S, Verma A, Cairns J. Contemporary atrial fibrillation management: A comparison of the current AHA/ACC/HRS, CCS, and ESC guidelines. Can J Cardiol 2017; 33: 965–976.
13. Furukawa Y, Miyake M, Fujita T, Koyama T, Takegami M, Kimura T, et al. Rationale, design, and baseline characteristics of the BioProsthetic Valves with Atrial Fibrillation (BPV-AF) Study. Cardiovasc Drugs Ther 2020; 34: 689–696.
4. Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol 2014; 6: 213–220.
10. Tsang TS, Abhayaratna WP, Barnes ME, Miyasaka Y, Gersh BJ, Bailey KR, et al. Prediction of cardiovascular outcomes with left atrial size: Is volume superior to area or diameter? J Am Coll Cardiol 2006; 47: 1018–1023.
16. Zhan Y, Joza J, Al Rawahi M, Barbosa RS, Samuel M, Bernier M, et al. Assessment and management of the left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Can J Cardiol 2018; 34: 252–261.
8. Fatema K, Bailey KR, Petty GW, Meissner I, Osranek M, Alsaileek AA, et al. Increased left atrial volume index: Potent biomarker for first-ever ischemic stroke. Mayo Clin Proc 2008; 83: 1107–1115.
19. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23: 685–713; quiz 786–788.
3. Ray S. Changing epidemiology and natural history of valvular heart disease. Clin Med (Lond) 2010; 10: 168–171.
11. Shiraki H, Tanaka H, Yamauchi Y, Yoshigai Y, Yamashita K, Tanaka Y, et al. Characteristics of non-valvular atrial fibrillation with left atrial appendage thrombus who are undergoing appropriate oral anticoagulation therapy. Int J Cardiovasc Imaging 2022; 38: 941–951.
1. Committee for Scientific Affairs, The Japanese Association for Thoracic Surgery; Shimizu H, Endo S, Natsugoe S, Doki Y, Hirata Y, et al. Thoracic and cardiovascular surgery in Japan in 2016: Annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg 2019; 67: 377–411.
2. Hollenberg SM. Valvular heart disease in adults: Etiologies, classification, and diagnosis. FP Essent 2017; 457: 11–16.
14. Izumi C, Miyake M, Fujita T, Koyama T, Tanaka H, Ando K, et al. Antithrombotic therapy for patients with atrial fibrillation and bioprosthetic valves: Real-world data from the multicenter, prospective, observational BPV-AF Registry. Circ J 2022; 86: 440–448.
9. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002; 90: 1284–1289.
6. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37: 2893–2962.
20. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 2022; 43: 561–632.
18. Stoddard MF, Singh P, Dawn B, Longaker RA. Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am Heart J 2003; 145: 676–682.
12. Suwa Y, Miyasaka Y, Taniguchi N, Harada S, Nakai E, Shiojima I. Atrial fibrillation and stroke: Importance of left atrium as assessed by echocardiography. J Echocardiogr 2022; 20: 69–76.
15. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015; 16: 233–270.
7. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014; 64: e1–e76.
5. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998; 98: 946–952.
11
12
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
10
References_xml – ident: 2
– ident: 3
  doi: 10.7861/clinmedicine.10-2-168
– ident: 10
  doi: 10.1016/j.jacc.2005.08.077
– ident: 1
  doi: 10.1007/s11748-019-01068-9
– ident: 6
  doi: 10.5603/KP.2016.0172
– ident: 16
  doi: 10.1016/j.cjca.2017.12.008
– ident: 12
  doi: 10.1007/s12574-021-00561-6
– ident: 15
  doi: 10.1093/ehjci/jev014
– ident: 8
  doi: 10.4065/83.10.1107
– ident: 13
  doi: 10.1007/s10557-020-07038-1
– ident: 20
  doi: 10.1093/ejcts/ezac209
– ident: 5
  doi: 10.1161/01.CIR.98.10.946
– ident: 19
  doi: 10.1016/j.echo.2010.05.010
– ident: 4
  doi: 10.2147/CLEP.S47385
– ident: 11
  doi: 10.1007/s10554-021-02403-z
– ident: 7
– ident: 9
  doi: 10.1016/S0002-9149(02)02864-3
– ident: 18
  doi: 10.1067/mhj.2003.91
– ident: 14
  doi: 10.1253/circj.CJ-21-0564
– ident: 17
  doi: 10.1016/j.cjca.2017.06.002
SSID ssj0002144510
Score 1.8826141
Snippet Background: The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the...
The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the utility of LAVI...
Background: The left atrial volume index (LAVI) is important for predicting thromboembolism in patients with non-valvular atrial fibrillation (AF), but the...
SourceID pubmedcentral
proquest
crossref
pubmed
jstage
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 210
SubjectTerms Atrial fibrillation
Bioprosthetic valve replacement
Left atrial volume index
Original article
Thromboembolism
Valvular Heart Disease
Title Association of Left Atrial Size With Stroke or Systemic Embolism in Patients With Atrial Fibrillation Having Undergone Bioprosthetic Valve Replacement From the BPV-AF Registry
URI https://www.jstage.jst.go.jp/article/circrep/5/5/5_CR-23-0007/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/37180478
https://www.proquest.com/docview/2813886764
https://pubmed.ncbi.nlm.nih.gov/PMC10166667
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Circulation Reports, 2023/05/10, Vol.5(5), pp.210-216
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELboigMXBOJVWNAgcUNpN3Gep1W3NOoBULWFhVvkOHabpUmqNOXAn-IvMuMk3RZxIjl6rDiZif2NPfMNY-98R_iRsNFT1e4FOigys6JAaCsUme2kws-0yVubL4PP38MPM6LJ8ftcGBO0L9N8VG6KUZmvTWzltpDjPk5svPg0JY8Tr2A8YAMEh0c-Os2_RAKGltZlyDgeH8u8Rgi2HU2vLYdTHnVwsgrdv0UgtlL_wph_h0oerT3xI_awA40waQf3mN1T5RP2--jLQqXho9INTEwVDljmvxR8y5s1LJu6-qGgqqHlJs8lzIq02uS7AvISFi2t6q4V7nrHlAawaYPkYC5oywFMfaRVVSq4yqstpYqsKf0RbsTmpwKE8bQdTzuNENdVAdgKV4sbaxJj28pUlHvKvsazL9O51ZVfsKTLg8aKQtfTOiSSJiezlesrqbxA-yrzFSIz5fLUloImCZcoYOxMR7a48AhzSD_MHP6MnZU4rhcMNOcR-jHKiZR0dYput9SuRjDKid4u40P2vldHsm1ZNhLyTlB5Sae8ZHqdOJzOyoMhu2w1dpDtjOMg65n7rsedwFrUOB8M2dte1Qn-TnRGIkpV7XcJvgcPQz_w3SF73qr-8BSO6ziRGQ1ZeGIUBwGi6j5tQQs2lN29xb78_66v2AMqdW8Z5thzdtbUe_WaDXbZ_o2x_z9UTBKf
link.rule.ids 230,315,729,782,786,887,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbYBQkuPMSry2uQuKG0SZznCXVLoyK6q2q7LNwi17HbsG1SpSkH_hR_kZk8ui3itMnRY8XRjO1v7JlvGPvg2cILhYWeqnZMdFBkYoS-0EYgEsueCS_RVd7aaOqf_wg-D4kmx2tzYaqgfTlLu9ly1c3SRRVbuV7JXhsn1pucDcjjxMfvHbG7OGFNc89LpxWYaMDQ1pocGdvlPZkWCMLW3cGFYXPKpPYP9qF7PxGKzdX_UOa_wZJ7u0_06LbjfsweNngT-nX7E3ZHZU_Znz2lQK5hrHQJ_aqAB0zT3wq-p-UCpmWRXyvIC6hpzVMJw9UsX6abFaQZTGpG1k0t3PSOKINgWcfXwUjQaQVUpZXmeabgNM3XlGWyoMxJuBLLXwrQA6CTfDqkhKjIV4CtcDq5MvoRts2rYnTP2LdoeDkYGU3lBkM63C-NMHBcrQPid7ITSzmeksr1tacSTyGoUw6fWVLQ-uIQe4yV6NASpktwRXpBYvPn7DjDcb1koDkP0QVSdqiko2fosUvtaMSxnJjxEt5hH1s9xuuaoCMmxwa1HjdajwcXsc3pmt3vsE-1qneyjX52sm713vS4EViIApeSDnvf2kiMM5GuV0Sm8u0mxv_gQeD5ntNhL2qb2X2FIwQgHqQOCw6saSdALN-HLWhEFdt3azQnt-_6jt0fXZ6N4_GX86-v2APbtKuYTct8zY7LYqvesKNNsn1bTaK_omMoWQ
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELbYBSEuPMSrPAeJG0qb2GkeXFC326iIZVVtYeEWuY7dBtokSlMO_Cn-IjNJ2m0RJ0iOHiuOZmzPZ898w9hrj0svlA4iVePaCFBUYoW-NFYgE4fPpJeYOm9tPPXPvwanI6LJebvNhamD9tUs7WbLVTdLF3VsZbFSvW2cWG_ycUiIEx-_VySmd8Su46S1-R5Sp1WYqMDQ3to8Gd4XPZWW6IgV3eGFxQVlU_sHe9GNb-iOzfXfPM0_Ayb3dqDozv-M_S673fqdMGhk7rFrOrvPfu0pB3IDZ9pUMKgLecA0_anhS1otYFqV-XcNeQkNvXmqYLSa5ct0vYI0g0nDzLpuhNveEWUSLJs4OxhLOrWAusTSPM80nKR5QdkmC8qghEu5_KEBkQCd6NNhJURlvgJshZPJpTWIsG1eF6V7wD5Ho0_DsdVWcLCUK_zKCgO3b0xAPE88cbTraaX7vvF04ml07rQrZo6StM64xCLjJCZ0pN0nt0V5QcLFQ3ac4bgeMzBChAiFNA-1cs0MkbsyrkF_VhBDXiI67M1Wl3HREHXEBHBQ83Gr-Xh4EXNB1-1-h71r1L2TbXW0k-3X71WPK4GFLHFJ6bBXWzuJcUbSNYvMdL5Zx_gfIgg833M77FFjN7uvCHQFiA-pw4IDi9oJENv3YQsaUs36vTWcJ__e9SW7OTmN4rP35x-eslvc5nXopmM_Y8dVudHP2dE62byo59Fvt9Yq2Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+Left+Atrial+Size+With+Stroke+or+Systemic+Embolism+in+Patients+With+Atrial+Fibrillation+Having+Undergone+Bioprosthetic+Valve+Replacement+From+the+BPV-AF+Registry&rft.jtitle=Circulation+reports&rft.au=Tanaka%2C+Hidekazu&rft.au=Takegami%2C+Misa&rft.au=Miyake%2C+Makoto&rft.au=Amano%2C+Masashi&rft.date=2023-05-10&rft.issn=2434-0790&rft.eissn=2434-0790&rft.volume=5&rft.issue=5&rft.spage=210&rft_id=info:doi/10.1253%2Fcircrep.CR-23-0007&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2434-0790&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2434-0790&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2434-0790&client=summon